Dolomite’s Command of Microfluidics Leads to Sales Growth and Expansion (January 2010)

Microfluidic pioneers Dolomite are celebrating expansion of their sales team and growth of over 200% during the past year. With numerous new product launches throughout the year, Dolomite has been able to provide both standard solutions and custom designs for microfluidic devices, sub-systems and instrumentation.

Dolomite are fast becoming a world leader in the development and manufacture of the microfluidic chips and connectors that are used in such industries as drug discovery, drug delivery, forensics and clinical diagnostics.

Microfluidics, a technology also known as ‘lab on a chip’, is an exciting new field of science and engineering that enables very small-scale fluid control and analysis, allowing instrument manufacturers to develop smaller, more cost-effective and more powerful systems.

With lab-on-a-chip technology, entire complex chemical management and analysis systems are created in a microfluidic chip and interfaced with, for example, electronic and optical detection systems.

2010 shows great promise with an expanded team, including two recently appointed European Business Development Managers, and an increasing demand from existing and new sectors.

Andrew Lovatt, newly-appointed CEO, commented, “Microfluidics is becoming increasingly important in many sectors and Dolomite’s offerings cover everything from standard devices to complete bespoke instrumentation development. As a result, we are uniquely positioned to assist our clients in maximising their success in this exciting new market.”

Having launched six new products, including the Mitos XS-pump and the Mitos P-Pump (pressure) for extra smooth flow, as well as eight new standard micro-fluidic devices such as the Y-junction Chip and the Mitos Droplet Junction Chip, Dolomite is rapidly increasing its product range to meet user requirements.

With an extended range of production processes, Dolomite has mastered the optimisation of quartz microfluidic chip fabrication. Consequently, instrument manufacturers not only benefit from this expertise and experience, but also from the properties of synthetic quartz within bioscience and medical systems.